Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-25 @ 11:24 PM
Study NCT ID:
NCT00783393
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2008-10-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
SCH 52365 Phase II Clinical Study: A Study on the Efficacy and Safety of Monotherapy With SCH 52365 in Patients With First Relapsed Anaplastic Astrocytoma (Study P03745)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2005-06-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-06-17
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-30
First Submit QC Date:
None
Study First Post Date:
2008-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-12
Last Update Post Date:
2017-05-15
Last Update Post Date Type:
ACTUAL